US/UK/Canada

Share

About Us

Karo Pharma is a specialty pharma company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment.

Contacts

  • Karo Pharma
    Nybrokajen 7, 111 48 Stockholm Sweden
    +46 8 608 60 00
    http://www.karopharma.se
  • Carl Lindgren

    Vice President


    +46 76 002 60 22
    • Pick a time period -
    Tags ( Active)

    Karo Pharma publishes the 2021 annual report

    Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company’s website, www.karopharma.com.     For further information, please contact:Lisa Westerdahl, Head of Corporate Communication, 073-329 70 04, lisa.westerdahl@karopharma.comJon Johnsson, CFO, 073-507 88 61, jon.johnsson@karopharma.com     The Annual Report is published in Swedish and English. The Swedish version represents the original version and has been translated into English.   This information is information that Karo Pharma is obliged to make public pursuant to the

    Annual Report 2011

    Stockholm, May 22, 2012 – Karo Bio AB’s annual report for 2011 is as of today available on the company’s website www.karobio.com.The printed version of the annual report will be distributed to shareholders and others specifically subscribing to the printed version. It can also be ordered from Karo Bio by mail to Karo Bio AB, attn: Eva Kruse, Novum, 141 57 Huddinge, Sweden, by fax to +46 8 774 8261, or by e-mail to eva.kruse@karobio.se.  For further information please contact: Per Bengtsson, CEOPhone: +46 76 002 6020   About Karo Bio Karo Bio is a research and development

    KARO BIO’S ANNUAL REPORT NOW AVAILABLE

    Stockholm, March 25, 2011 – Karo Bio AB’s annual report for 2010 is as of today available on the company’s website www.karobio.com.The printed version of the annual report will be distributed to shareholders and others specifically subscribing to the printed version. It can also be ordered from Karo Bio by mail to Karo Bio AB, attn: Eva Kruse, Novum, 141 57 Huddinge, Sweden, by fax to +46 8 774 52 80, or by e-mail to investor@karobio.com. For further information please contact Fredrik Lindgren, CEOPhone: +46 70 561 61 77 Erika Söderberg Johnson, CFOPhone: +46 8 608 60 52

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe